Risk factors for chronic kidney disease: An update

Kidney International Supplements

Volumn 3, Issue 4, 2013, Pages 368-371

  Kazancioǧlu, Rumeyza ^a  

^a BEZMIALEM VAKIF UNIVERSITY   (Turkey)

Author keywords

Age; chronic kidney disease; diabetes mellitus; gender; hypertension

Indexed keywords

ANALGESIC AGENT; HEAVY METAL;

ACUTE KIDNEY FAILURE; AGE; ALCOHOL CONSUMPTION; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; CREATININE BLOOD LEVEL; DIABETES MELLITUS; END STAGE RENAL DISEASE; ETHNICITY; FAMILY HISTORY; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERLIPIDEMIA; HYPERTENSION; LOW BIRTH WEIGHT; METABOLIC SYNDROME X; NEPHROTOXICITY; OBESITY; RACE DIFFERENCE; RENAL REPLACEMENT THERAPY; RISK FACTOR; SEX DIFFERENCE; SMOKING; SOCIAL STATUS; URINALYSIS;

EID: 84896736285     PISSN: 21571724     EISSN: 21571716     Source Type: Journal    
DOI: 10.1038/kisup.2013.79     Document Type: Conference Paper

References (32)

1. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047
2. Suleymanlar G, Utas C, Arinsoy T et al. A population-based survey of Chronic REnal Disease In Turkey - the CREDIT study. Nephrol Dial Transplant 2011; 26: 1862-1871
3. McClellan WM, Flanders WD. Risk factors for progressive chronic kidney disease. J Am Soc Nephrol 2003; 14: S65-S70
4. Kottgen A, Glazer NL, Dehghan A et al. Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet 2009; 41: 712-717
5. Pollak MR, Genovese G, Friedman DJ. APOL1 and kidney disease. Curr Opin Nephrol Hypertens 2012; 21: 179-182
6. Su SL, Lu KC, Lin YF et al. Gene polymorphisms of angiotensin-converting enzyme and angiotensin II type 1 receptor among chronic kidney disease patients in a Chinese population. J Renin Angiotensin Aldosterone Syst 2012; 13: 148-154
7. Song EY, McClellan WM, Mc Clellan A et al. Effect of community characteristics on familial clustering of end-stage renal disease. Am J Nephrol 2009; 30: 499-504
8. Iseki K. Factors influencing the development of end-stage renal disease. Clin Exp Nephrol 2005; 9: 5-14
9. Takamatsu N, Abe H, Tominaga T et al. Risk factors for chronic kidney disease in Japan: A community-based study. BMC Nephrol 2009; 10
10. Nzerue CM, Demissachew H, Tucker JK. Race and kidney disease: Role of social and environmental factors. J Natl Med Assoc 2002; 94: 28S-38S
11. Lackland DT, Egan BM, Fan ZJ et al. Low birth weight contributes to the excess prevalence of end-stage renal disease in African Americans. J Clin Hypertens (Greenwich) 2001; 3: 29-31
12. Falodia J, Singla MK. CKD epidemiology and risk factors. Clin Queries Nephrol 2012; 1: 249-252
13. Mackenzie HS, Lawler EV, Brenner BM. Congenital oligonephropathy: the fetal flaw in essential hypertensionKidney Int Suppl 1996; 55: S30-S34
14. Luyckx VA, Brenner BM. The clinical importance of nephron mass. J Am Soc Nephrol 2010; 21: 898-910
15. Vikse BE, Irgens LM, Leivestad T et al. Low birth weight increases risk for end-stage renal disease. J Am Soc Nephrol 2008; 19: 151-157
16. Chang A, Kramer H. CKD progression: A risky business. Nephrol Dial Transplant 2012; 27: 2607-2609
17. Ejerblad E, Michael Fored C, Lindblad P et al. Obesity and risk for chronic renal failure. J Am Soc Nephrol 2006; 17: 1695-1702
18. Mirrakhimov AE. Obstructive sleep apnea and kidney disease: Is there any direct linkSleep Breath 2012; 16: 1009-1016
19. Kwakernaak AJ, Zelle DM, Bakker SJL et al. Central body fat distribution associates with unfavorable renal hemodynamics independent of body mass index. J Am Soc Nephrol 2013; 24: 987-994
20. Plantinga LC. Socio-economic impact in CKD. Nephrologie Therapeutique 2013; 9: 1-7
21. Krop JS, Coresh J, Chambles LE et al. A community-based study of explanatory factors for the excess risk for early renal function decline in black vs whites' diabetes: the Atherosclerosis Risk in Communities study. Arch Intern Med 1999; 159: 1777-1783
22. Bleyer AJ, Shemanski LR, Burke GL et al. Tobacco, hypertension, and vascular disease: Risk factors for renal functional decline in an older population. Kidney Int 2000; 57: 2072-2079
23. Orth SR, Schroeder T, Ritz E et al. Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus. Nephrol Dial Transplant 2005; 20: 2414-2419
24. Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal anti-inflammatory drugs. N Eng J Med 1994; 25: 1675-1679
25. Goldstein SL, Devarajan P. Acute kidney injury in childhood: should we be worried about progression to CKDPediatr Nephrol 2011; 26: 509-522
26. Suleymanlar G, ỳparmak MR, Seyahi N et al. Registry of the Nephrology Dialysis and Transplantation in Turkey (Registry-2011) Istanbul: Published by the Turkish Society of Nephrology, 2011
27. Lea JP, Nicholas SB. Diabetes mellitus and hypertension: key risk factors for kidney disease. J Natl Med Assoc 2002; 94: 7S-15S
28. Shulman NB, Ford CE, Hall WD et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 1989; 13: I80-I93
29. Klag MJ, Whelton PK, Randall BL et al. Blood pressure and end stage renal disease in men. N Engl J Med 1996; 334: 13-18
30. Inoue T, Iseki K, Iseki C et al. Heart rate as a risk factor for developing chronic kidney disease: longitudinal analysis of a screened cohort. Clin Exp Nephrol 2009; 13: 487-493
31. Pradeep AR, Kathariya R, Raju A et al. Risk factors for chronic kidney diseases may include periodontal diseases, as estimated by the correlations of plasma pentraxin-3 levels: A case-control study. Int Urol Nephrol 2012; 44: 829-839
32. Obermayr RP, Temml C, Gutjahr G et al. Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol 2008; 19: 2407-2413